维生素A制剂辅助布地奈德治疗支气管哮喘患儿临床疗效及对免疫功能的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

国家自然科学基金青年基金


Effects of vitamin a preparation combined with budesonide on immune function of children with bronchial asthma
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】目的 探讨维生素A制剂辅助布地奈德治疗支气管哮喘患儿临床疗效及对免疫功能的影响。方法 选取2015年3月~2017年5月本院收治的122例支气管哮喘患儿为研究对象,按治疗方式不同分为对照组和观察组,每组各61例。两组患儿入院后均按照支气管哮喘常规治疗,对照组在常规治疗基础上给予布地奈德治疗,观察组在对照组的基础上加维生素A辅助治疗,两组均治疗4周。比较两组患儿治疗前后免疫功能、哮喘症状、血清IL17、IL10及TGFβ1水平变化以及对两组患儿临床疗效、不良反应的影响。结果 治疗前两组体液免疫IgA、IgG、IgM水平比较差异无统计学意义(P>0.05),治疗后两组IgA、IgG、IgM明显升高,观察组明显高于对照组(P<0.05);治疗前两组T细胞亚群CD3+、CD4+、CD8+、CD4+/CD8+水平比较差异无统计学意义(P>0.05),治疗后两组CD3+、CD4+、CD8+明显升高,观察组明显高于对照组(P<0.05);治疗前两组IL17、IL10及TGFβ1水平无明显差异(P>0.05),治疗后两组IL17均明显降低,观察组低于对照组(P<0.05),两组IL10及TGFβ1均升高,观察组明显高于对照组(P<0.05);治疗后两组哮喘症状评分均明显下降,观察组低于对照组(P<0.05);观察组临床有效率明显高于对照组(P<0.05);对照组不良反应发生率组间比较差异无统计学意义(P>0.05)。结论 采用维生素A辅助布地奈德治疗支气管哮喘患儿,可有效的缓解患儿症状,促进治疗效果,提高患者免疫水平,安全性可靠,可作为有效治疗支气管哮喘患儿的临床治疗方法之一。

    Abstract:

    【Abstract】 Objective To investigate the effects of vitamin A preparation combined with budesonide on immune function of children with bronchial asthma. Methods〓122 children with bronchial asthma treated in our hospital from March 2015 to May 2017 were selected and divided into control group and observation group, according to different treatment methods. All children received the routine treatment, based on this, the control group received the budesonide, while the observation group received the vitamin A preparation combined with budesonide, both tid. for 4 weeks. The immune function, asthma symptoms, serum IL17, IL10, and TGFβ1 levels, clinical efficacy and adverse reactions in the two groups were compared. Results The levels of humoral immunity IgA, IgG and IgM between the two groups had no difference before treatment (P>0.05), and were increased after treatment. The levels of humoral immunity IgA, IgG and IgM in the observation group were higher than those in the control group after treatment (P<0.05). The levels of CD3+, CD4+, CD8+, and CD4+/CD8+ in T cell subsets had no difference before treatment (P>0.05), and above levels except CD4+/CD8+ were increased after treatment. The levels of CD3+, CD4+, CD8+, and CD4+/CD8+ in T cell subsets in the observation group were higher than those in the control group (P<0.05). The levels of IL17, IL10 and TGFβ1 between the two groups had no difference before treatment (P>0.05), and the IL17 level was decreased in both groups, the IL10 and TGFβ1 levels were increased on both groups. Both of the decreasing and increasing degrees were more significant in the observation group than in the control group (P<0.05). The asthma symptoms scores of the two groups were decreased significantly. The asthma symptoms scores in the observation group were lower than those in the control group (P<0.05). The clinical efficiency of the observation group was significantly higher than that of the control group (P<0.05). The incidence of adverse reactions was 820% in the control group, which was not significantly different in observation group (P>0.05). Conclusion The vitamin A preparation combined with budesonide can safely and effectively relieve the symptoms, promote therapeutic effects and improve the immune level of children with bronchial asthma.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-05-23
您是第位访问者
版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司